In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels
2021 · Nature Biotechnology · 359 citations
https://doi.org/10.1038/s41587-021-00933-4
R
Rurika Oka
Oncode Institute(NL)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
3.3K
Citations
20
h-index
22
i10-index
Rurika Oka is an academic researcher from Oncode Institute. The author has contributed to research in topics: Cancer Research and Treatments & Acute Myeloid Leukemia Research & CRISPR and Genetic Engineering. The author has an h-index of 20, co-authored 63 publications.
ORCID: 0000-0003-4107-7250Papers by this author
worksAn organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
2020 · Nature Communications · 301 citations
https://doi.org/10.1038/s41467-020-15155-6
Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis
2018 · Cell Reports · 241 citations
https://doi.org/10.1016/j.celrep.2018.11.014
Prime editing for functional repair in patient-derived disease models
2020 · Nature Communications · 219 citations
https://doi.org/10.1038/s41467-020-19136-7
MutationalPatterns: the one stop shop for the analysis of mutational processes
2022 · BMC Genomics · 173 citations
https://doi.org/10.1186/s12864-022-08357-3
Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
2021 · Life Science Alliance · 133 citations
https://doi.org/10.26508/lsa.202000940
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat